Tianjin Lisheng Pharmaceutical Co Ltd Cash Flow Conversion Efficiency

Latest as of December 2025: 0.061x

Tianjin Lisheng Pharmaceutical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Tianjin Lisheng Pharmaceutical Co Ltd (002393) has a cash flow conversion efficiency ratio of 0.061x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥287.81 Million ≈ $42.12 Million USD) by net assets (CN¥4.69 Billion ≈ $686.81 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Tianjin Lisheng Pharmaceutical Co Ltd (2007–2025)

Cash flow conversion efficiency of Tianjin Lisheng Pharmaceutical Co Ltd from 2007 to 2025. This chart illustrates how Tianjin Lisheng Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 002393 live share price for real-time trading data and today's change.

Tianjin Lisheng Pharmaceutical Co Ltd Cash Flow Conversion Ratio Explained

Tianjin Lisheng Pharmaceutical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Tianjin Lisheng Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tianjin Lisheng Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Also see 002393 market cap for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Sayona Mining Ltd AU:SYA	0.041x
Musti Group Oyj HE:MUSTI	0.079x
TFE Co. Ltd. KQ:425420	0.015x
J.S. Corrugating Machinery Co Ltd SHE:000821	0.038x
Autohellas S.A. AT:OTOEL	0.064x
Oeneo SA PA:SBT	0.161x
Medistim ASA OL:MEDI	0.098x
Suzhou Alton Electrical & Mechanical Industry Co. Ltd. SHE:301187	-0.070x

Annual Cash Flow Conversion Efficiency for Tianjin Lisheng Pharmaceutical Co Ltd (2007–2025)

The table below shows the annual cash flow conversion efficiency of Tianjin Lisheng Pharmaceutical Co Ltd from 2007 to 2025. Review Tianjin Lisheng Pharmaceutical Co Ltd free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥4.69 Billion ≈ $686.81 Million	CN¥451.85 Million ≈ $66.12 Million	0.096x	+423.55%
2024-12-31	CN¥4.80 Billion ≈ $702.39 Million	CN¥88.26 Million ≈ $12.92 Million	0.018x	-56.96%
2023-12-31	CN¥4.90 Billion ≈ $717.53 Million	CN¥209.51 Million ≈ $30.66 Million	0.043x	-43.92%
2022-12-31	CN¥4.35 Billion ≈ $636.45 Million	CN¥331.38 Million ≈ $48.49 Million	0.076x	+71.15%
2021-12-31	CN¥4.41 Billion ≈ $645.40 Million	CN¥196.34 Million ≈ $28.73 Million	0.045x	+150.77%
2020-12-31	CN¥4.30 Billion ≈ $629.53 Million	CN¥76.37 Million ≈ $11.18 Million	0.018x	-70.78%
2019-12-31	CN¥4.42 Billion ≈ $646.32 Million	CN¥268.33 Million ≈ $39.26 Million	0.061x	+19.96%
2018-12-31	CN¥3.21 Billion ≈ $470.07 Million	CN¥162.69 Million ≈ $23.81 Million	0.051x	-12.99%
2017-12-31	CN¥3.08 Billion ≈ $450.66 Million	CN¥179.25 Million ≈ $26.23 Million	0.058x	+1.09%
2016-12-31	CN¥3.02 Billion ≈ $441.21 Million	CN¥173.60 Million ≈ $25.40 Million	0.058x	-13.70%
2015-12-31	CN¥2.97 Billion ≈ $434.60 Million	CN¥198.13 Million ≈ $28.99 Million	0.067x	+168.73%
2014-12-31	CN¥2.91 Billion ≈ $425.81 Million	CN¥72.24 Million ≈ $10.57 Million	0.025x	-74.94%
2013-12-31	CN¥2.92 Billion ≈ $427.86 Million	CN¥289.62 Million ≈ $42.38 Million	0.099x	+10.09%
2012-12-31	CN¥2.79 Billion ≈ $407.77 Million	CN¥250.72 Million ≈ $36.69 Million	0.090x	+87.07%
2011-12-31	CN¥2.80 Billion ≈ $409.46 Million	CN¥134.58 Million ≈ $19.69 Million	0.048x	-31.68%
2010-12-31	CN¥2.65 Billion ≈ $387.79 Million	CN¥186.55 Million ≈ $27.30 Million	0.070x	-83.10%
2009-12-31	CN¥470.87 Million ≈ $68.90 Million	CN¥196.14 Million ≈ $28.70 Million	0.417x	+56.23%
2008-12-31	CN¥474.77 Million ≈ $69.47 Million	CN¥126.59 Million ≈ $18.52 Million	0.267x	-34.13%
2007-12-31	CN¥432.23 Million ≈ $63.25 Million	CN¥174.94 Million ≈ $25.60 Million	0.405x	--

About Tianjin Lisheng Pharmaceutical Co Ltd

SHE:002393 China Drug Manufacturers - Specialty & Generic

Market Cap

$579.25 Million

CN¥3.96 Billion CNY

Market Cap Rank

#11118 Global

#3021 in China

Share Price

CN¥12.84

Change (1 day)

+2.97%

52-Week Range

CN¥12.47 - CN¥24.25

All Time High

CN¥46.19